IBIO

$0.00

(

0.00%

)
Quote details

stock

iBio, Inc. Common Stock

NYSE MKT | IBIO

0.78

USD

$0.00

(

0.00%

)

AT CLOSE (AS OF Aug 26, 2025)

$13.72M

MARKET CAP

-

P/E Ratio

-0.04

EPS

$6.89

52 Week High

$0.55

52 Week Low

LIFE SCIENCES

Sector

IBIO Chart

Recent Chart
Price Action

IBIO Technicals

Tags:

IBIO Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field Value (USD)
Gross Profit $225K
Total Revenue $225K
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$17M
Selling General And Administrative $12M
Research And Development $5.2M
Operating Expenses $17M
Investment Income Net -
Net Interest Income $191K
Interest Income $363K
Interest Expense $172K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$15M
Income Tax Expense $9.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$15M
Comprehensive Income Net Of Tax -
Ebit -$15M
Ebitda -$14M
Net Income -$25M

Revenue & Profitability

Earnings Performance

IBIO Financials

yearly Balance Sheet (As of Jun 30, 2024)

Field Value (USD)
Total Assets $29M
Total Current Assets $16M
Cash And Cash Equivalents At Carrying Value $14M
Cash And Short Term Investments $14M
Inventory -
Current Net Receivables $713K
Total Non Current Assets $13M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $5.4M
Intangible Assets Excluding Goodwill $5.4M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $749K
Other Non Current Assets -
Total Liabilities $7.4M
Total Current Liabilities $3.8M
Current Accounts Payable $358K
Deferred Revenue -
Current Debt -
Short Term Debt $953K
Total Non Current Liabilities $3.6M
Capital Lease Obligations $3.5M
Long Term Debt $766K
Current Long Term Debt $218K
Long Term Debt Noncurrent -
Short Long Term Debt Total $4.5M
Other Current Liabilities $2.3M
Other Non Current Liabilities -
Total Shareholder Equity $21M
Treasury Stock -
Retained Earnings -$314M
Common Stock $9K
Common Stock Shares Outstanding $3.8M

yearly Cash Flow (As of Jun 30, 2024)

Field Value (USD)
Operating Cashflow -$19M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $210K
Change In Receivables -
Change In Inventory $0
Profit Loss -
Cashflow From Investment $906K
Cashflow From Financing $24M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$25M

yearly Income Statement (As of Jun 30, 2024)

Field Value (USD)
Gross Profit $225K
Total Revenue $225K
Cost Of Revenue $1.3M
Costof Goods And Services Sold $1.3M
Operating Income -$17M
Selling General And Administrative $12M
Research And Development $5.2M
Operating Expenses $17M
Investment Income Net -
Net Interest Income $191K
Interest Income $363K
Interest Expense $172K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$15M
Income Tax Expense $9.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$15M
Comprehensive Income Net Of Tax -
Ebit -$15M
Ebitda -$14M
Net Income -$25M

IBIO Profile

iBio, Inc. Common Stock Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.

IXHL
-5.50%
$0.69
ALLR
+55.21%
$1.46
CGBS
-39.47%
$0.03
TNFA
+13.72%
$0.07
IVVD
+84.02%
$1.03
HKPD
+35.23%
$1.42
NIO
+9.93%
$6.69
TLRY
+3.95%
$1.44
NVDA
+1.13%
$181.84
EPIX
-66.43%
$0.26
BENF
+7.32%
$0.41
PFSA
-16.06%
$0.41
PLTR
+2.35%
$160.87
AIFF
+4.63%
$2.71
RR
+32.76%
$3.15
LCID
+1.68%
$2.11
DNN
+6.49%
$2.21
TSLA
+1.46%
$351.67
INTC
-0.81%
$24.35
WBA
-0.35%
$11.92
TPIC
-45.91%
$0.12
SOUN
-0.74%
$12.02
AXDX
-61.36%
$0.03
SOFI
-2.31%
$25.54
AAL
+1.15%
$13.15
STKH
+22.76%
$0.66
SNAP
-2.77%
$7.00
KDP
-6.63%
$29.03
LYT
-16.77%
$0.09
AMD
+1.99%
$166.62
F
+0.12%
$11.83
AAPL
+0.94%
$229.31
OPAD
+2.47%
$3.73
RIVN
+0.15%
$13.11
SATS
+70.24%
$50.87
MRKR
-20.63%
$1.01
NUKK
+17.40%
$5.80
MARA
+3.51%
$15.94
ONDS
+1.99%
$4.94
BMNR
+1.10%
$50.14
ATNF
-6.81%
$3.07
RMBL
+60.50%
$3.21
RGTI
+5.73%
$15.30
ADD
-25.47%
$0.05
PLUG
-1.19%
$1.65
BAC
+1.51%
$50.23
VHAI
0.00%
$0.00
SRM
+53.27%
$10.30
ETHD
-6.60%
$3.25
JOBY
+2.65%
$14.68
WULF
+3.46%
$9.23
RAYA
-10.20%
$0.04
IQ
-2.48%
$2.35
ITUB
-0.94%
$6.80
BBD
-0.50%
$2.98
RIOT
+2.03%
$13.55
ABEV
0.00%
$2.20
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MSFT
-0.44%
$502.04
WLGS
-5.57%
$0.04
GPRO
+6.36%
$1.75
GOOGL
-0.64%
$207.14
CVE
+0.14%
$16.72
T
-0.99%
$28.45
CGC
+1.61%
$1.46
KEY
+1.49%
$19.30
ETWO
0.00%
$3.30
AUR
-2.18%
$5.82
TME
+1.94%
$26.22
WBD
-0.95%
$11.92
AVGO
+1.28%
$298.01
ADAP
+7.20%
$0.06
OKLO
+4.39%
$74.31
VRAX
-18.17%
$0.63
APLD
-0.62%
$15.95
CIFR
+5.83%
$7.02
AFMD
-34.94%
$0.18
SBET
+4.25%
$19.98
QBTS
+2.79%
$15.44
RKLB
+2.23%
$48.27
HIMS
+5.71%
$45.44
PTHL
+14.90%
$0.64
UP
+26.40%
$3.02
WMT
-0.05%
$96.02
CSX
-1.50%
$32.31
PFE
-0.79%
$24.94
HL
+1.71%
$7.99
AMCR
-2.06%
$8.52
BTBT
+1.07%
$2.81
HOOD
+0.12%
$108.07
RF
+1.66%
$27.09
RAY
-20.12%
$2.50
NOK
-1.38%
$4.28
CRML
+9.04%
$6.87
SMCI
+0.43%
$44.07
UUUU
+3.30%
$10.93
IBIO
-6.94%
$0.78
IREN
-1.07%
$22.87
BTG
+2.14%
$4.03
IXHL
-5.50%
$0.69
ALLR
+55.21%
$1.46
CGBS
-39.47%
$0.03
TNFA
+13.72%
$0.07
IVVD
+84.02%
$1.03
HKPD
+35.23%
$1.42
NIO
+9.93%
$6.69
TLRY
+3.95%
$1.44
NVDA
+1.13%
$181.84
EPIX
-66.43%
$0.26
BENF
+7.32%
$0.41
PFSA
-16.06%
$0.41
PLTR
+2.35%
$160.87
AIFF
+4.63%
$2.71
RR
+32.76%
$3.15
LCID
+1.68%
$2.11
DNN
+6.49%
$2.21
TSLA
+1.46%
$351.67
INTC
-0.81%
$24.35
WBA
-0.35%
$11.92
TPIC
-45.91%
$0.12
SOUN
-0.74%
$12.02
AXDX
-61.36%
$0.03
SOFI
-2.31%
$25.54
AAL
+1.15%
$13.15
STKH
+22.76%
$0.66
SNAP
-2.77%
$7.00
KDP
-6.63%
$29.03
LYT
-16.77%
$0.09
AMD
+1.99%
$166.62
F
+0.12%
$11.83
AAPL
+0.94%
$229.31
OPAD
+2.47%
$3.73
RIVN
+0.15%
$13.11
SATS
+70.24%
$50.87
MRKR
-20.63%
$1.01
NUKK
+17.40%
$5.80
MARA
+3.51%
$15.94
ONDS
+1.99%
$4.94
BMNR
+1.10%
$50.14
ATNF
-6.81%
$3.07
RMBL
+60.50%
$3.21
RGTI
+5.73%
$15.30
ADD
-25.47%
$0.05
PLUG
-1.19%
$1.65
BAC
+1.51%
$50.23
VHAI
0.00%
$0.00
SRM
+53.27%
$10.30
ETHD
-6.60%
$3.25
JOBY
+2.65%
$14.68
WULF
+3.46%
$9.23
RAYA
-10.20%
$0.04
IQ
-2.48%
$2.35
ITUB
-0.94%
$6.80
BBD
-0.50%
$2.98
RIOT
+2.03%
$13.55
ABEV
0.00%
$2.20
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MSFT
-0.44%
$502.04
WLGS
-5.57%
$0.04
GPRO
+6.36%
$1.75
GOOGL
-0.64%
$207.14
CVE
+0.14%
$16.72
T
-0.99%
$28.45
CGC
+1.61%
$1.46
KEY
+1.49%
$19.30
ETWO
0.00%
$3.30
AUR
-2.18%
$5.82
TME
+1.94%
$26.22
WBD
-0.95%
$11.92
AVGO
+1.28%
$298.01
ADAP
+7.20%
$0.06
OKLO
+4.39%
$74.31
VRAX
-18.17%
$0.63
APLD
-0.62%
$15.95
CIFR
+5.83%
$7.02
AFMD
-34.94%
$0.18
SBET
+4.25%
$19.98
QBTS
+2.79%
$15.44
RKLB
+2.23%
$48.27
HIMS
+5.71%
$45.44
PTHL
+14.90%
$0.64
UP
+26.40%
$3.02
WMT
-0.05%
$96.02
CSX
-1.50%
$32.31
PFE
-0.79%
$24.94
HL
+1.71%
$7.99
AMCR
-2.06%
$8.52
BTBT
+1.07%
$2.81
HOOD
+0.12%
$108.07
RF
+1.66%
$27.09
RAY
-20.12%
$2.50
NOK
-1.38%
$4.28
CRML
+9.04%
$6.87
SMCI
+0.43%
$44.07
UUUU
+3.30%
$10.93
IBIO
-6.94%
$0.78
IREN
-1.07%
$22.87
BTG
+2.14%
$4.03

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.